Is prednisone (corticosteroid) safe to use during breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Safety During Breastfeeding

Prednisone is safe to use during breastfeeding, with doses ≤20 mg daily requiring no special precautions, while doses >20 mg daily require a 4-hour delay between administration and breastfeeding to minimize infant exposure. 1, 2

Dose-Specific Safety Guidelines

Low-Dose Prednisone (≤20 mg daily)

  • The American College of Rheumatology strongly recommends prednisone at doses less than 20 mg daily as fully compatible with breastfeeding without any interruption or special timing considerations. 1, 2
  • The relative infant dose at this level is considered safe, typically representing less than 10% of the maternal dose. 1
  • Continue breastfeeding normally on your regular schedule without any modifications. 1, 3
  • The European Society of Cardiology similarly endorses the use of the lowest effective doses of prednisone throughout breastfeeding, with calcium and vitamin D supplementation recommended for the mother. 4

High-Dose Prednisone (>20 mg daily)

  • For doses exceeding 20 mg daily, women should delay breastfeeding or discard breast milk accumulated in the 4 hours following glucocorticoid administration. 1, 2, 3
  • This timing recommendation minimizes infant exposure to peak drug concentrations in breast milk. 1
  • Plan medication administration around the infant's longest sleep interval to facilitate the 4-hour waiting period. 1
  • If breast engorgement occurs during the 4-hour window, pump and discard that milk. 3

Clinical Implementation Algorithm

Step 1: Determine the minimum effective dose needed for maternal disease control 1

  • Prioritize maintaining maternal disease control, as untreated maternal illness poses risks to both mother and infant. 1, 3

Step 2: Apply dose-specific recommendations

  • If ≤20 mg daily is sufficient: No special precautions needed—breastfeed normally. 1, 2, 3
  • If >20 mg daily is required: Implement the 4-hour delay strategy. 1, 2, 3

Step 3: Coordinate timing strategically

  • Administer prednisone immediately after a breastfeeding session or before the infant's longest sleep period. 1
  • This maximizes the interval between peak drug levels and the next feeding. 3

Evidence Quality and Consensus

The recommendations are based on strong evidence from the American College of Rheumatology and EULAR (European Alliance of Associations for Rheumatology), with high-quality evidence supporting low-dose use and conditional recommendations with timing precautions for high-dose use. 1 The European Society of Cardiology guidelines for pericardial diseases also support prednisone use throughout breastfeeding. 4

Common Pitfalls to Avoid

  • Do not use higher doses than necessary for disease control. 3 Always aim for the minimum effective dose.
  • Do not fail to plan medication timing around the breastfeeding schedule when using doses >20 mg daily. 3 This is the most critical intervention for high-dose therapy.
  • Do not discontinue breastfeeding unnecessarily. 1, 2 The benefits of breastfeeding are substantial, and prednisone can be used safely with appropriate precautions.

Multidisciplinary Coordination

Collaboration between rheumatologists, primary care physicians, and pediatricians is recommended when managing breastfeeding women on corticosteroid therapy to ensure coordinated care that balances maternal disease control with infant safety. 1, 2

Additional Considerations

  • Short-term use of prednisone poses particularly low risk to the infant. 2
  • Alternative anti-inflammatory medications such as NSAIDs (ibuprofen, indomethacin, naproxen) may also be considered compatible with breastfeeding for short-term use if appropriate for the maternal condition. 4, 2
  • The FDA label notes that systemically administered corticosteroids appear in human milk, but the guideline-based approach above provides the specific safety thresholds and management strategy. 5

References

Guideline

Prednisone Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prednisone Safety During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Safety of Steroids During Breastfeeding

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.